CLINICAL STUDIES
Circulating chlamydia pneumoniae DNA as a predictor of coronary artery disease
Yuk-ki Wong, BSc, (Hons), MRCP*  ,
Keith D. Dawkins, FRCP, FACC and
Michael E. Ward, PhD*
* Molecular Microbiology Department, Southampton University Medical School, Southampton, United Kingdom
Wessex Cardiothoracic Unit, Southampton General Hospital, Southampton, United Kingdom
Manuscript received October 30, 1998;
revised manuscript received March 10, 1999,
accepted July 6, 1999.
Reprint requests and correspondence: Dr. Yuk-ki Wong, Wessex Cardiothoracic Unit, Southampton General Hospital, Tremona Road, Southampton, Hampshire, United Kingdom S016 6YD
YW2{at}soton.ac.uk
OBJECTIVE
To determine whether current vascular Chlamydia pneumoniae (CPn) infection as diagnosed by circulating CPn DNA is more common in subjects with coronary artery disease (CAD).
BACKGROUND
Serological, pathological and animal studies have associated CPn with CAD and preliminary trials suggest antibiotics may prevent adverse coronary events. C. pneumoniae is thought to disseminate systemically within macrophages. We therefore detected CPn DNA in blood to determine whether its presence was a predictor of CAD.
METHODS
One thousand, two hundred and five subjects attending for diagnostic and interventional coronary arteriography were recruited. The mononuclear cell layer and platelets were separated from collected blood and the polymerase chain reaction (PCR) was used to detect CPn DNA.
RESULTS
Circulating CPn DNA was found in 8.8% of 669 men with CAD compared with 2.9% of 135 men with normal coronary arteries (odds ratio [OR] 3.2, 95% confidence interval [CI] 1.1–8.9). In men with CAD, those with CPn DNA had higher mean platelet counts than those without CPn DNA. Monocyte counts and indirect fibrinogen levels were also raised but not significantly so. By contrast, no association of circulating CPn DNA and CAD was seen in women.
CONCLUSIONS
Circulating CPn DNA is a predictor of CAD in men. Unlike serology, it is a specific indicator of current infection and is a means of identifying subjects who may potentially benefit from antichlamydial therapy.
|
Abbreviations and Acronyms
| | CAD | = coronary artery disease | | CI | = confidence interval | | CPn | = Chlamydia pneumoniae | | OR | = odds ratio | | PBS | = phosphate buffered saline | | PCR | = polymerase chain reaction |
|
This article has been cited by other articles:
|
|
|
|
 
R. Mitusch, J. Luedemann, W. G. Wood, K. Berger, U. Schminke, M. Suter, C. Kessler, U. John, J. Rupp, M. Kentsch, et al.
Asymptomatic Carotid Atherosclerosis Is Associated With Circulating Chlamydia pneumoniae DNA in Younger Normotensive Subjects in a General Population Survey
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2005;
25(2):
386 - 391.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Zibaeenezhad, A. Amanat, A. Alborzi, and A. Obudi
Relation of Chlamydia Pneumoniae Infection to Documented Coronary Artery Disease in Shiraz, Southern Iran
Angiology,
January 1, 2005;
56(1):
43 - 48.
[Abstract]
[PDF]
|
|
|
|
|
|
|
V. Y. Hoymans, J. M. Bosmans, D. Ursi, W. Martinet, F. L. Wuyts, E. Van Marck, M. Altwegg, C. J. Vrints, and M. M. Ieven
Immunohistostaining Assays for Detection of Chlamydia pneumoniae in Atherosclerotic Arteries Indicate Cross-Reactions with Nonchlamydial Plaque Constituents
J. Clin. Microbiol.,
July 1, 2004;
42(7):
3219 - 3224.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Baboonian, D. A Smith, D. Shapland, G. Arno, B. Zal, J. Akiyu, and J. C. Kaski
Placental infection with Chlamydia pneumoniae and intrauterine growth restriction
Cardiovasc Res,
October 15, 2003;
60(1):
165 - 169.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kamath and G.Y.H. Lip
Fibrinogen: biochemistry, epidemiology and determinants
QJM,
October 1, 2003;
96(10):
711 - 729.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Agmon, B. K. Khandheria, I. Meissner, T. M. Petterson, W. M. O'Fallon, T. J. H. Christianson, D. O. Wiebers, T. F. Smith, J. M. Steckelberg, and A. J. Tajik
Lack of association between Chlamydia pneumoniae seropositivity and aortic atherosclerotic plaques: A Population-Based transesophageal echocardiographic study
J. Am. Coll. Cardiol.,
May 7, 2003;
41(9):
1482 - 1487.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Tsirpanlis, S. Chatzipanagiotou, A. Ioannidis, S. Moutafis, C. Poulopoulou, and C. Nicolaou
Detection of Chlamydia pneumoniae in peripheral blood mononuclear cells: correlation with inflammation and atherosclerosis in haemodialysis patients
Nephrol. Dial. Transplant.,
May 1, 2003;
18(5):
918 - 923.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Apfalter, O. Assadian, F. Blasi, J. Boman, C. A. Gaydos, M. Kundi, A. Makristathis, M. Nehr, M. L. Rotter, and A. M. Hirschl
Reliability of Nested PCR for Detection of Chlamydia pneumoniae DNA in Atheromas: Results from a Multicenter Study Applying Standardized Protocols
J. Clin. Microbiol.,
December 1, 2002;
40(12):
4428 - 4434.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Yamamoto
PCR in Diagnosis of Infection: Detection of Bacteria in Cerebrospinal Fluids
Clin. Vaccine Immunol.,
May 1, 2002;
9(3):
508 - 514.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D Taylor-Robinson, B J Thomas, R Goldin, and R Stanbridge
Chlamydia pneumoniae in infrequently examined blood vessels
J. Clin. Pathol.,
March 1, 2002;
55(3):
218 - 220.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E Roeters van Lennep, H.T. Westerveld, D.W. Erkelens, and E. E van der Wall
Risk factors for coronary heart disease: implications of gender
Cardiovasc Res,
February 15, 2002;
53(3):
538 - 549.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Tavendale, D. Parratt, S.D. Pringle, R. A'brook, and H. Tunstall-Pedoe
Serological markers of Chlamydia pneumoniae infection in men and women and subsequent coronary events. The Scottish Heart Health Study Cohort
Eur. Heart J.,
February 2, 2002;
23(4):
301 - 307.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. C. Tondella, D. F. Talkington, B. P. Holloway, S. F. Dowell, K. Cowley, M. Soriano-Gabarro, M. S. Elkind, and B. S. Fields
Development and Evaluation of Real-Time PCR-Based Fluorescence Assays for Detection of Chlamydiapneumoniae
J. Clin. Microbiol.,
February 1, 2002;
40(2):
575 - 583.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Boman and M. R. Hammerschlag
Chlamydia pneumoniae and Atherosclerosis: Critical Assessment of Diagnostic Methods and Relevance to Treatment Studies
Clin. Microbiol. Rev.,
January 1, 2002;
15(1):
1 - 20.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. Smieja, J. B. Mahony, C. H. Goldsmith, S. Chong, A. Petrich, and M. Chernesky
Replicate PCR Testing and Probit Analysis for Detection and Quantitation of Chlamydia pneumoniae in Clinical Specimens
J. Clin. Microbiol.,
May 1, 2001;
39(5):
1796 - 1801.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
D. Katritsis, S. Korovesis, E. Giazitzoglou, J. Parissis, P. Kalivas, M. M. Webb-Peploe, J. P.A. Ioannidis, and A. Haliassos
C-Reactive Protein Concentrations and Angiographic Characteristics of Coronary Lesions
Clin. Chem.,
May 1, 2001;
47(5):
882 - 886.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Smieja, S. Chong, M. Natarajan, A. Petrich, L. Rainen, and J. B. Mahony
Circulating Nucleic Acids of Chlamydia pneumoniae and Cytomegalovirus in Patients Undergoing Coronary Angiography
J. Clin. Microbiol.,
February 1, 2001;
39(2):
596 - 600.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
J. Gieffers, H. Fullgraf, J. Jahn, M. Klinger, K. Dalhoff, H. A. Katus, W. Solbach, and M. Maass
Chlamydia pneumoniae Infection in Circulating Human Monocytes Is Refractory to Antibiotic Treatment
Circulation,
January 23, 2001;
103(3):
351 - 356.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Kaul, J. Uphoff, J. Wiedeman, S. Yadlapalli, and W. M. Wenman
Detection of Chlamydia pneumoniae DNA in CD3+ Lymphocytes From Healthy Blood Donors and Patients With Coronary Artery Disease
Circulation,
November 7, 2000;
102(19):
2341 - 2346.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Taylor-Robinson and B. J. Thomas
Coronary heart disease and chlamydia pneumoniae DNA in blood mononuclear cells
J. Am. Coll. Cardiol.,
August 1, 2000;
36(2):
657 - 658.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-k. Wong, K. D. Dawkins, and M. E. Ward
Reply
J. Am. Coll. Cardiol.,
August 1, 2000;
36(2):
658 - 658.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. B. Mahony, S. Chong, B. K. Coombes, M. Smieja, and A. Petrich
Analytical Sensitivity, Reproducibility of Results, and Clinical Performance of Five PCR Assays for Detecting Chlamydia pneumoniae DNA in Peripheral Blood Mononuclear Cells
J. Clin. Microbiol.,
July 1, 2000;
38(7):
2622 - 2627.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
T. J. Bodetti and P. Timms
Detection of Chlamydia pneumoniae DNA and Antigen in the Circulating Mononuclear Cell Fractions of Humans and Koalas
Infect. Immun.,
May 1, 2000;
68(5):
2744 - 2747.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
